نتائج البحث - "etanercept"

1

Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration

المساهمون: HUS Inflammation Center, Department of Medicine, Reumatologian yksikkö, Repositório da Universidade de Lisboa

المصدر: Annals of the Rheumatic Diseases
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Lindström, U, Di Giuseppe, D, Delcoigne, B, Glintborg, B, Möller, B, Ciurea, A, Pombo-Suarez, M, Sanchez-Piedra, C, Eklund, K, Relas, H, Gudbjornsson, B, Love, T J, Jones, G T, Codreanu, C, Ionescu, R, Nekvindova, L, Závada, J, Atas, N, Yolbas, S, Fagerli, K M, Michelsen, B, Rotar, Tomšič, M, Iannone, F, Santos, M J, Avila-Ribeiro, P, Ørnbjerg, L M, Østergaard, M, Jacobsson, L T H, Askling, J & Nissen, M J 2021, ' Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration ', Annals of the Rheumatic Diseases, vol. 80, no. 11, 220097, pp. 1410-1418 . https://doi.org/10.1136/annrheumdis-2021-220097Test

مصطلحات موضوعية: Male, Placebo-controlled study, Psoriatic, PLACEBO-CONTROLLED TRIAL, THERAPY, Etanercept, DOUBLE-BLIND, 0302 clinical medicine, Immunology and Allergy, Medicine, 030212 general & internal medicine, skin and connective tissue diseases, Remission Induction, Middle Aged, Tumour necrosis factor inhibitors, Treatment Outcome, arthritis, Antirheumatic Agents, Drug Therapy, Combination, Female, medicine.drug, musculoskeletal diseases, Adult, medicine.medical_specialty, Immunology, Psoriatic Arthritis, tumour necrosis factor inhibitors, General Biochemistry, Genetics and Molecular Biology, methotrexate, 03 medical and health sciences, Psoriatic arthritis, Rheumatology, Internal medicine, Adalimumab, Humans, 030203 arthritis & rheumatology, business.industry, Arthritis, Arthritis, Psoriatic, EFFICACY, medicine.disease, Infliximab, Discontinuation, Methotrexate, 3121 General medicine, internal medicine and other clinical medicine, Tumor Necrosis Factor Inhibitors, psoriatic, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::022e520d9e5e31bc0cc0baf6321a0476Test
http://europepmc.org/articles/PMC8522446Test

2

Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study

المؤلفون: Dimitrios A Pappas, Kelechi Emeanuru, T. Blachley, Susan Boklage, Jeannie Choi, Gregory St John, Rajeshwari S. Punekar, Toshio Kimura, Stefano Fiore, Carol J. Etzel, Joel M. Kremer

المصدر: Annals of the Rheumatic Diseases

مصطلحات موضوعية: Male, rheumatoid arthritis, DMARDs (biologic), Etanercept, Arthritis, Rheumatoid, chemistry.chemical_compound, Piperidines, Immunology and Allergy, Registries, Certolizumab pegol, Antibodies, Monoclonal, Middle Aged, Treatment Outcome, Rheumatoid arthritis, Antirheumatic Agents, Female, Rituximab, medicine.drug, TNF-alpha, Adult, musculoskeletal diseases, medicine.medical_specialty, Immunology, Antibodies, Monoclonal, Humanized, General Biochemistry, Genetics and Molecular Biology, Abatacept, outcomes research, Tocilizumab, Rheumatology, Internal medicine, medicine, Adalimumab, Humans, Patient Reported Outcome Measures, Propensity Score, Aged, Biological Products, business.industry, Recommendation, medicine.disease, Golimumab, Infliximab, Interleukin 1 Receptor Antagonist Protein, Pyrimidines, chemistry, Certolizumab Pegol, Tumor Necrosis Factor Inhibitors, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e6fed49555e547330f49728cc647103Test
http://europepmc.org/articles/PMC7788059Test

3

Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs: a randomised, double-blind, placebo-controlled phase III trial (RAJ3)

المؤلفون: Yeong Wook Song, Manabu Iwasaki, Tsutomu Takeuchi, James Cheng-Chung Wei, Yuichiro Kaneko, Yoshiya Tanaka, Satoshi Ushijima, Rio Akazawa, Emi Yamada, Sang-Heon Lee, Mitsuhiro Rokuda, Yi Hsing Chen, Teruaki Shiomi, Hiroyuki Izutsu, Sakae Tanaka, Atsushi Kawakami

المصدر: Annals of the Rheumatic Diseases

مصطلحات موضوعية: musculoskeletal diseases, Adult, Male, Niacinamide, medicine.medical_specialty, dmards (synthetic), Immunology, Rheumatoid Arthritis, Adamantane, Blood Sedimentation, Placebo, Infections, Herpes Zoster, Severity of Illness Index, General Biochemistry, Genetics and Molecular Biology, Etanercept, Arthritis, Rheumatoid, Rheumatology, Double-Blind Method, Japan, Internal medicine, medicine, Clinical endpoint, Immunology and Allergy, DAS28, Humans, Janus Kinase Inhibitors, In patient, Adverse effect, skin and connective tissue diseases, Janus kinase inhibitor, Aged, treatment, business.industry, Drug Substitution, Middle Aged, medicine.disease, C-Reactive Protein, Treatment Outcome, Rheumatoid arthritis, Antirheumatic Agents, Female, business, disease activity, Immunosuppressive Agents, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56406f5a17409c934613c80065f2f965Test
http://europepmc.org/articles/PMC6788921Test

4

Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis

المؤلفون: Marita Jansson, Ronald F van Vollenhoven, Till Uhlig, Mikkel Østergaard, Esbjörn Larsson, Fiona Brock, Marjatta Leirisalo-Repo, Karin Franck-Larsson

المساهمون: Rheumatology, AII - Inflammatory diseases

المصدر: van Vollenhoven, R F, Østergaard, M, Leirisalo-Repo, M, Uhlig, T, Jansson, M, Larsson, E, Brock, F & Franck-Larsson, K 2016, ' Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis ', Annals of the Rheumatic Diseases, vol. 75, no. 1, pp. 52-8 . https://doi.org/10.1136/annrheumdis-2014-205726Test
van Vollenhoven, R F, Østergaard, M, Leirisalo-Repo, M, Uhlig, T, Jansson, M, Larsson, E, Brock, F & Franck-Larsson, K 2016, ' Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis ', Annals of the Rheumatic Diseases, vol. 75, no. 1, pp. 52-88 . https://doi.org/10.1136/annrheumdis-2014-205726Test
Annals of the Rheumatic Diseases, 75(1), 52-8. BMJ Publishing Group
Annals of the Rheumatic Diseases

مصطلحات موضوعية: Male, Gastroenterology, Severity of Illness Index, law.invention, Etanercept, Anti-TNF, Arthritis, Rheumatoid, 0302 clinical medicine, Randomized controlled trial, law, Recurrence, Immunology and Allergy, 030212 general & internal medicine, skin and connective tissue diseases, Dose Reduced, Research Support, Non-U.S. Gov't, Middle Aged, Connective tissue disease, Treatment Outcome, Rheumatoid arthritis, Antirheumatic Agents, Randomized Controlled Trial, Drug Therapy, Combination, Female, medicine.drug, musculoskeletal diseases, Adult, medicine.medical_specialty, Immunology, Rheumatoid Arthritis, Placebo, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, Rheumatology, Double-Blind Method, Internal medicine, medicine, Journal Article, Humans, Aged, 030203 arthritis & rheumatology, business.industry, Clinical and Epidemiological Research, medicine.disease, Surgery, Discontinuation, Methotrexate, Withholding Treatment, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92d8a1232df4b50f58cf6818fff824b6Test
https://doi.org/10.1136/annrheumdis-2014-205726Test

5

Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment

المؤلفون: Sinisa Savic, C. Wong, Kimme L. Hyrich, Anne Barton, Anthony G. Wilson, Sarah M Churchman, Darren Plant, Michael F. McDermott, Steve Eyre, Jennifer H. Barrett, Piercarlo Sarzi-Puttini, Rebeccah J. Mathews, James I. Robinson, John D. Isaacs, John C. Taylor, Ann W. Morgan, M. Battellino, Graham P. Cook, Paul Emery

المصدر: Annals of the Rheumatic Diseases; Vol 73

مصطلحات موضوعية: Male, Inflammasomes, Etanercept, Arthritis, Rheumatoid, 0302 clinical medicine, Immunology and Allergy, Medicine, skin and connective tissue diseases, 0303 health sciences, integumentary system, Caspase 1, Middle Aged, MEFV, 3. Good health, Neoplasm Proteins, Rheumatoid arthritis, Antirheumatic Agents, Tumor necrosis factor alpha, Female, medicine.drug, musculoskeletal diseases, Adult, Genotype, Immunology, Single-nucleotide polymorphism, Polymorphism, Single Nucleotide, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, Rheumatology, NLR Family, Pyrin Domain-Containing 3 Protein, Adalimumab, Humans, Genetic Predisposition to Disease, RNA, Messenger, 030304 developmental biology, Aged, 030203 arthritis & rheumatology, business.industry, Tumor Necrosis Factor-alpha, Gene Expression Profiling, Pyrin, medicine.disease, Infliximab, CARD Signaling Adaptor Proteins, Cytoskeletal Proteins, Case-Control Studies, Expression quantitative trait loci, Multivariate Analysis, Linear Models, business, Carrier Proteins

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20b508b8f4830786156631147b5633e8Test

6

Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study

المؤلفون: Mittie K. Doyle, Jonathan Kay, Eric L. Matteson, Stephen Xu, Josef S Smolen, Yiying Zhou, Robert Landewé, Elizabeth C. Hsia

المساهمون: AII - Amsterdam institute for Infection and Immunity, Clinical Immunology and Rheumatology

المصدر: Annals of the Rheumatic Diseases
Annals of the rheumatic diseases, 73(10), 1811-1818. BMJ Publishing Group

مصطلحات موضوعية: Male, medicine.medical_treatment, Pharmacology, Gastroenterology, Severity of Illness Index, Receptors, Tumor Necrosis Factor, Etanercept, Anti-TNF, Arthritis, Rheumatoid, Immunology and Allergy, skin and connective tissue diseases, Drug Substitution, Antibodies, Monoclonal, Middle Aged, TNF inhibitor, Treatment Outcome, Rheumatoid arthritis, Antirheumatic Agents, Drug Therapy, Combination, Female, medicine.drug, musculoskeletal diseases, Adult, medicine.medical_specialty, Injections, Subcutaneous, Immunology, Rheumatoid Arthritis, Placebo, Antibodies, Monoclonal, Humanized, General Biochemistry, Genetics and Molecular Biology, Drug Administration Schedule, Rheumatology, Internal medicine, medicine, Adalimumab, DAS28, Humans, Aged, business.industry, Tumor Necrosis Factor-alpha, Clinical and Epidemiological Research, medicine.disease, Infliximab, Golimumab, Methotrexate, Immunoglobulin G, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::215cf9e2349ccfe75aa13b54ce7138faTest
http://europepmc.org/articles/PMC4173740Test

7

Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules

المصدر: Annals of the Rheumatic Diseases. 71(11):1820-1826

مصطلحات موضوعية: Male, musculoskeletal diseases, medicine.medical_specialty, Immunology, Arthritis, Kaplan-Meier Estimate, Antibodies, Monoclonal, Humanized, Receptors, Tumor Necrosis Factor, General Biochemistry, Genetics and Molecular Biology, Etanercept, Arthritis, Rheumatoid, chemistry.chemical_compound, Tocilizumab, Rheumatology, Risk Factors, Internal medicine, medicine, Humans, Immunology and Allergy, Prospective Studies, Registries, Adverse effect, Prospective cohort study, skin and connective tissue diseases, Proportional Hazards Models, Tumor Necrosis Factor-alpha, business.industry, Antibodies, Monoclonal, Middle Aged, medicine.disease, Infliximab, Discontinuation, Surgery, Survival Rate, Withholding Treatment, chemistry, Antirheumatic Agents, Immunoglobulin G, Rheumatoid arthritis, Female, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6265011e333ab01b1bb00a48abb3452bTest
https://nagasaki-u.repo.nii.ac.jp/records/10014Test

8

A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial

المؤلفون: Juergen Braun, Désirée van der Heijde, Antoine Feydy, Jean Sibilia, Véronique Leblanc, Alain Cantagrel, Maxime Dougados, Bernard Combe, Robert Landewé, Isabelle Logeart

المساهمون: Other departments, Interne Geneeskunde, RS: CAPHRI School for Public Health and Primary Care

المصدر: Annals of the rheumatic diseases, 69(8), 1430-1435. BMJ Publishing Group
Annals of the Rheumatic Diseases, 69(8), 1430-1435. BMJ Publishing Group

مصطلحات موضوعية: Adult, Male, musculoskeletal diseases, medicine.medical_specialty, Heel, WOMAC, Immunology, Placebo-controlled study, Placebo, General Biochemistry, Genetics and Molecular Biology, Receptors, Tumor Necrosis Factor, Etanercept, Psoriatic arthritis, Young Adult, Rheumatology, Spondylarthritis, medicine, Immunology and Allergy, Humans, business.industry, Tumor Necrosis Factor-alpha, Anti-Inflammatory Agents, Non-Steroidal, Enthesitis, Middle Aged, medicine.disease, Infliximab, Calcaneus, medicine.anatomical_structure, Treatment Outcome, Antirheumatic Agents, Immunoglobulin G, Tendinopathy, Physical therapy, Female, medicine.symptom, business, Epidemiologic Methods, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec2ef8df422410649c9070f4598dc847Test
https://doi.org/10.1136/ard.2009.121533Test

9

Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA

المؤلفون: G. Worthy, Elizabeth M A Hensor, Josef S. Smolen, Paul Emery, R. van Vollenhoven, Maya H Buch, Guido Valesini, Kevin L. Winthrop, Robert Landewe, Karel Pavelka, Jackie L Nam

المساهمون: Interne Geneeskunde, RS: CAPHRI School for Public Health and Primary Care

المصدر: Annals of the Rheumatic Diseases, 69(6), 976-986. BMJ Publishing Group

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f11dadeeb2350547866098496ab5463cTest
https://doi.org/10.1136/ard.2009.126573Test

10

Exposure to nuclear antigens contributes to the induction of humoral autoimmunity during tumour necrosis factor alpha blockade

المؤلفون: Timothy B. Niewold, P. P. Tak, Mary K. Crow, Carla A. Wijbrandts, Clio P. Mavragani, Dominique Baeten, T Niers, Bernard Vandooren, Tineke Cantaert, Eric Veys, D Richel, L De Rycke

المساهمون: Clinical Immunology and Rheumatology, Center of Experimental and Molecular Medicine, CCA -Cancer Center Amsterdam, Oncology, AII - Amsterdam institute for Infection and Immunity, Faculteit der Geneeskunde

المصدر: Annals of the rheumatic diseases, 68(6), 1022-1029. BMJ Publishing Group
Annals of the Rheumatic Diseases, 68(6), 1022-1029. BMJ Publishing Group

مصطلحات موضوعية: Male, Anti-nuclear antibody, Apoptosis, medicine.disease_cause, Receptors, Tumor Necrosis Factor, Etanercept, Autoimmunity, Interferon, immune system diseases, Immunology and Allergy, Medicine, skin and connective tissue diseases, TUNEL assay, Synovial Membrane, Antibodies, Monoclonal, Complement C4, Complement C3, Middle Aged, Nucleosomes, Antibodies, Antinuclear, Antirheumatic Agents, Interferon Type I, Female, medicine.drug, Adult, musculoskeletal diseases, medicine.medical_specialty, Immunology, General Biochemistry, Genetics and Molecular Biology, Statistics, Nonparametric, Article, Young Adult, Rheumatology, Internal medicine, Spondylarthritis, Humans, Aged, Autoantibodies, business.industry, Infliximab, stomatognathic diseases, Immunoglobulin M, Immunoglobulin G, Humoral immunity, Antibody Formation, Tumor Necrosis Factor Inhibitors, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1937775cd0e66cfce7cf14c46447dfc6Test
https://hdl.handle.net/11245/1.320244Test

تنقيح النتائج